Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134831) titled 'tudy on the Diagnostic, Therapeutic Monitoring, and Follow-up Value of Urinary Extracellular Vesicles and Antibody Testing in Patients with Membranous Nephropathy' on Oct. 21.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
membranous nephropathy
Intervention:
Gold Standard:Case group: Patients diagnosed with MN by renal biopsy, or meeting the clinical diagnostic criteria recommended by the 2021 KDIGO guidelines (positive PLA2R antibodies and typical clinical manifestations). Control group: Patients diagnosed with other...